Danielle Fink

Leidos (United States) — United States

Medicine · Health Sciences

17h-index2.2kcitations48works6.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(10), Neutrophil, Myeloperoxidase and Oxidative Mechanisms(9), Brain Metastases and Treatment(9), Immunodeficiency and Autoimmune Disorders(8), SARS-CoV-2 and COVID-19 Research(7)

Publications48 total

Reliable genetic diagnosis of NCF1 (p47phox)-deficient chronic granulomatous disease using high-throughput sequencing
Frontiers in Immunology·2025Open Access
Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
JCI Insight·2025· 4 citedOpen Access
Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to <scp>JAK</scp> Inhibitor and Dazukibart Therapy
Arthritis & Rheumatology·2025· 5 citedOpen Access
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature
Science Immunology·2025· 9 citedOpen Access
Germline mutations in a G protein identify signaling cross-talk in T cells
Science·2024· 19 citedOpen Access
Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects
UNC Libraries·2024· 1 citedOpen Access
Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19
Cell Reports Medicine·2024· 14 citedOpen Access
Longitudinal Analysis of the Lung Proteome Reveals Persistent Repair Months after Mild to Moderate COVID-19
SSRN Electronic Journal·2024· 1 citedOpen Access
Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
Science Advances·2023· 9 citedOpen Access
Anakinra‐Associated Systemic Amyloidosis
Arthritis & Rheumatology·2023· 10 citedOpen Access
Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling
Nature Communications·2023· 18 citedOpen Access
Evolution of the Proteomic Landscape in the Lungs of Patients With SARS-CoV-2 Infection
2023
Supplementary Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Supplementary materials-Neutrophil chemotaxis videos from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Supplementary materials-Neutrophil chemotaxis videos from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Supplementary Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Supplementary materials-Clinical trial protocol from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Data from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
Supplementary materials-Clinical trial protocol from Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Douglas B. Kuhns(43), Michail S. Lionakis(17), Steven M. Holland(17), John I. Gallin(15), Luigi D. Notarangelo(14), Katherine R. Calvo(13), Ottavia M. Delmonte(12), Kerry Dobbs(11), Amy P. Hsu(11), Debra A. Long Priel(11), Cody J. Peer(10), William D. Figg(10), Alexandra F. Freeman(9), Stefania Pittaluga(9), Tristan M. Sissung(9), Ying Pang(9), Guangyang Yu(9), Madison Butler(9), Tito R. Mendoza(9), Elizabeth Vera(9)